Tadmor B, Rubinow A, Shalit M
Allergy and Clinical Immunology Unit, Hebrew University-Hadassah Medical School, Jerusalem.
Harefuah. 1993 Jun 1;124(11):683-5, 739.
We describe a 39-year-old man who suffered from delayed pressure urticaria for 2 years. His severe symptoms did not respond to antihistamine (H1 and H2) treatment and corticosteroid therapy was given despite severe side-effects. A new, nonsedating antihistamine drug, cetirizine, relieved most of his symptoms, enabled him to be weaned from corticosteroid therapy, and restored his former quality of life.
我们描述了一名39岁的男性,他患有迟发性压力性荨麻疹达2年之久。他的严重症状对抗组胺药(H1和H2)治疗无反应,尽管有严重的副作用,仍给予了皮质类固醇治疗。一种新型的非镇静性抗组胺药物西替利嗪缓解了他的大部分症状,使他能够逐渐停用皮质类固醇治疗,并恢复了他以前的生活质量。